H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulphonamide) induces autophagy independently of protein kinase A inhibition

Hiroko Inoue, Katsunori Hase, Arata Segawa, Tsuyoshi Takita

    研究成果: Article

    8 引用 (Scopus)

    抄録

    Autophagy is a degradation pathway for cytoplasmic proteins and organelles in eukaryotes. Although the mechanisms of autophagy regulation are not completely understood, the target of rapamycin (TOR) signaling pathway plays a major role in controlling the induction of autophagy. Cyclic adenosine monophosphate (cAMP)/cAMP-dependent protein kinase A (PKA) has also been shown to regulate autophagy in yeast and mammalian cells. In an effort to elucidate the role of the cAMP/PKA pathway in autophagy, we used the PKA inhibitor N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulphonamide (H89) to treat mammalian cells. Our data demonstrated that H89 induced autophagy at 10 μM, which is a commonly used concentration for PKA inhibition, but PKA inhibition was not involved in the induction of autophagy. The effects of cAMP on autophagy seemed to be dependent on the cell type and the culture conditions. In addition, we investigated which protein kinase was involved in H89-induced autophagy because several kinases other than PKA have been shown to be inhibited by 10 μM of H89. There was no protein kinase largely responsible for autophagy induction, although the inhibition of Akt, which is a downstream effector protein kinase of phosphatidylinositol-3-kinase, appeared to be partially associated. Furthermore, H89-induced autophagy was independent of TOR. H89 is a widely used PKA inhibitor, but PKA-independent effects have been reported. Therefore, it is suggested that autophagy induction is a nonspecific effect of H89, and H89-induced autophagy is independent of the cAMP-PKA and the TOR pathways.

    元の言語English
    ページ(範囲)170-177
    ページ数8
    ジャーナルEuropean Journal of Pharmacology
    714
    発行部数1-3
    DOI
    出版物ステータスPublished - 2013

    Fingerprint

    Autophagy
    Cyclic AMP-Dependent Protein Kinases
    Sirolimus
    Cyclic AMP
    Protein Kinases
    Protein Kinase Inhibitors
    N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide
    Phosphatidylinositol 3-Kinase
    Adenosine Monophosphate
    Eukaryota
    Organelles
    Phosphotransferases
    Cell Culture Techniques
    Yeasts

    ASJC Scopus subject areas

    • Pharmacology

    これを引用

    H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulphonamide) induces autophagy independently of protein kinase A inhibition. / Inoue, Hiroko; Hase, Katsunori; Segawa, Arata; Takita, Tsuyoshi.

    :: European Journal of Pharmacology, 巻 714, 番号 1-3, 2013, p. 170-177.

    研究成果: Article

    Inoue, Hiroko ; Hase, Katsunori ; Segawa, Arata ; Takita, Tsuyoshi. / H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulphonamide) induces autophagy independently of protein kinase A inhibition. :: European Journal of Pharmacology. 2013 ; 巻 714, 番号 1-3. pp. 170-177.
    @article{8f8bda3d429742988a906691ed7258ab,
    title = "H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulphonamide) induces autophagy independently of protein kinase A inhibition",
    abstract = "Autophagy is a degradation pathway for cytoplasmic proteins and organelles in eukaryotes. Although the mechanisms of autophagy regulation are not completely understood, the target of rapamycin (TOR) signaling pathway plays a major role in controlling the induction of autophagy. Cyclic adenosine monophosphate (cAMP)/cAMP-dependent protein kinase A (PKA) has also been shown to regulate autophagy in yeast and mammalian cells. In an effort to elucidate the role of the cAMP/PKA pathway in autophagy, we used the PKA inhibitor N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulphonamide (H89) to treat mammalian cells. Our data demonstrated that H89 induced autophagy at 10 μM, which is a commonly used concentration for PKA inhibition, but PKA inhibition was not involved in the induction of autophagy. The effects of cAMP on autophagy seemed to be dependent on the cell type and the culture conditions. In addition, we investigated which protein kinase was involved in H89-induced autophagy because several kinases other than PKA have been shown to be inhibited by 10 μM of H89. There was no protein kinase largely responsible for autophagy induction, although the inhibition of Akt, which is a downstream effector protein kinase of phosphatidylinositol-3-kinase, appeared to be partially associated. Furthermore, H89-induced autophagy was independent of TOR. H89 is a widely used PKA inhibitor, but PKA-independent effects have been reported. Therefore, it is suggested that autophagy induction is a nonspecific effect of H89, and H89-induced autophagy is independent of the cAMP-PKA and the TOR pathways.",
    keywords = "Akt, Autophagy, H89, Protein kinase A",
    author = "Hiroko Inoue and Katsunori Hase and Arata Segawa and Tsuyoshi Takita",
    year = "2013",
    doi = "10.1016/j.ejphar.2013.06.018",
    language = "English",
    volume = "714",
    pages = "170--177",
    journal = "European Journal of Pharmacology",
    issn = "0014-2999",
    publisher = "Elsevier",
    number = "1-3",

    }

    TY - JOUR

    T1 - H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulphonamide) induces autophagy independently of protein kinase A inhibition

    AU - Inoue, Hiroko

    AU - Hase, Katsunori

    AU - Segawa, Arata

    AU - Takita, Tsuyoshi

    PY - 2013

    Y1 - 2013

    N2 - Autophagy is a degradation pathway for cytoplasmic proteins and organelles in eukaryotes. Although the mechanisms of autophagy regulation are not completely understood, the target of rapamycin (TOR) signaling pathway plays a major role in controlling the induction of autophagy. Cyclic adenosine monophosphate (cAMP)/cAMP-dependent protein kinase A (PKA) has also been shown to regulate autophagy in yeast and mammalian cells. In an effort to elucidate the role of the cAMP/PKA pathway in autophagy, we used the PKA inhibitor N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulphonamide (H89) to treat mammalian cells. Our data demonstrated that H89 induced autophagy at 10 μM, which is a commonly used concentration for PKA inhibition, but PKA inhibition was not involved in the induction of autophagy. The effects of cAMP on autophagy seemed to be dependent on the cell type and the culture conditions. In addition, we investigated which protein kinase was involved in H89-induced autophagy because several kinases other than PKA have been shown to be inhibited by 10 μM of H89. There was no protein kinase largely responsible for autophagy induction, although the inhibition of Akt, which is a downstream effector protein kinase of phosphatidylinositol-3-kinase, appeared to be partially associated. Furthermore, H89-induced autophagy was independent of TOR. H89 is a widely used PKA inhibitor, but PKA-independent effects have been reported. Therefore, it is suggested that autophagy induction is a nonspecific effect of H89, and H89-induced autophagy is independent of the cAMP-PKA and the TOR pathways.

    AB - Autophagy is a degradation pathway for cytoplasmic proteins and organelles in eukaryotes. Although the mechanisms of autophagy regulation are not completely understood, the target of rapamycin (TOR) signaling pathway plays a major role in controlling the induction of autophagy. Cyclic adenosine monophosphate (cAMP)/cAMP-dependent protein kinase A (PKA) has also been shown to regulate autophagy in yeast and mammalian cells. In an effort to elucidate the role of the cAMP/PKA pathway in autophagy, we used the PKA inhibitor N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulphonamide (H89) to treat mammalian cells. Our data demonstrated that H89 induced autophagy at 10 μM, which is a commonly used concentration for PKA inhibition, but PKA inhibition was not involved in the induction of autophagy. The effects of cAMP on autophagy seemed to be dependent on the cell type and the culture conditions. In addition, we investigated which protein kinase was involved in H89-induced autophagy because several kinases other than PKA have been shown to be inhibited by 10 μM of H89. There was no protein kinase largely responsible for autophagy induction, although the inhibition of Akt, which is a downstream effector protein kinase of phosphatidylinositol-3-kinase, appeared to be partially associated. Furthermore, H89-induced autophagy was independent of TOR. H89 is a widely used PKA inhibitor, but PKA-independent effects have been reported. Therefore, it is suggested that autophagy induction is a nonspecific effect of H89, and H89-induced autophagy is independent of the cAMP-PKA and the TOR pathways.

    KW - Akt

    KW - Autophagy

    KW - H89

    KW - Protein kinase A

    UR - http://www.scopus.com/inward/record.url?scp=84885415578&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84885415578&partnerID=8YFLogxK

    U2 - 10.1016/j.ejphar.2013.06.018

    DO - 10.1016/j.ejphar.2013.06.018

    M3 - Article

    C2 - 23810683

    AN - SCOPUS:84885415578

    VL - 714

    SP - 170

    EP - 177

    JO - European Journal of Pharmacology

    JF - European Journal of Pharmacology

    SN - 0014-2999

    IS - 1-3

    ER -